Characterization of Visual Field Loss Over 4 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) Study.
Saved in:
| Title: | Characterization of Visual Field Loss Over 4 Years in the Rate of Progression in USH2A-Related Retinal Degeneration (RUSH2A) Study. |
|---|---|
| Authors: | Duncan JL; From the University of California (J.L.D.), San Francisco, California, USA., Maguire MG; Jaeb Center for Health Research (M.G.M., L.S.M., N.R.D., A.R.A., and P.C.), Tampa, Florida, USA., McDaniel LS; Jaeb Center for Health Research (M.G.M., L.S.M., N.R.D., A.R.A., and P.C.), Tampa, Florida, USA., Doucet NR; Jaeb Center for Health Research (M.G.M., L.S.M., N.R.D., A.R.A., and P.C.), Tampa, Florida, USA., Audo I; Institut de la Vision (I.A.), Sorbonne Université, INSERM, CNRS, Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts (I.A.), Paris, France., Ayala AR; Jaeb Center for Health Research (M.G.M., L.S.M., N.R.D., A.R.A., and P.C.), Tampa, Florida, USA. Electronic address: ffbcorrespauth@jaeb.org., Cheetham JK; Foundation Fighting Blindness (J.K.C. and T.A.D.), Columbia, Maryland, USA., Cheng P; Jaeb Center for Health Research (M.G.M., L.S.M., N.R.D., A.R.A., and P.C.), Tampa, Florida, USA., Durham TA; Foundation Fighting Blindness (J.K.C. and T.A.D.), Columbia, Maryland, USA., Huckfeldt RM; Massachusetts Eye and Ear (R.M.H.), Harvard Medical School, Boston, Massachusetts, USA., Hufnagel RB; Center for Integrated Health Care Research (R.B.H.), Kaiser Permanente, Honolulu, Hawaii, USA., Jayasundera KT; Department of Ophthalmology and Visual Sciences (K.T.J., N.K., B.M., and A.Z.), University of Michigan Medical School, Ann Arbor, Michigan, USA., Khan N; Department of Ophthalmology and Visual Sciences (K.T.J., N.K., B.M., and A.Z.), University of Michigan Medical School, Ann Arbor, Michigan, USA., Malbin B; Department of Ophthalmology and Visual Sciences (K.T.J., N.K., B.M., and A.Z.), University of Michigan Medical School, Ann Arbor, Michigan, USA., Maldonado RS; Duke University (R.S.M.), Duke Eye Center, Durham, North Carolina, USA., Michaelides M; Moorfields Eye Hospital and UCL Institute of Ophthalmology (M.M.), London, UK., Pennesi ME; Casey Eye Institute-Oregon Health and Science University (M.E.P., S.A., and H.I.), Portland, Oregon, USA; Retina Foundation of the Southwest (M.E.P. and D.G.B.), Dallas, Texas, USA., Weng CY; Baylor College of Medicine (C.Y.W.), Houston, Texas, USA., Zmejkoski A; Department of Ophthalmology and Visual Sciences (K.T.J., N.K., B.M., and A.Z.), University of Michigan Medical School, Ann Arbor, Michigan, USA., Aravind S; Casey Eye Institute-Oregon Health and Science University (M.E.P., S.A., and H.I.), Portland, Oregon, USA., Ishikawa H; Casey Eye Institute-Oregon Health and Science University (M.E.P., S.A., and H.I.), Portland, Oregon, USA., Birch DG; Retina Foundation of the Southwest (M.E.P. and D.G.B.), Dallas, Texas, USA. |
| Corporate Authors: | Foundation Fighting Blindness Clinical Consortium Investigator Group |
| Source: | American journal of ophthalmology [Am J Ophthalmol] 2025 Aug; Vol. 276, pp. 9-21. Date of Electronic Publication: 2025 Mar 27. |
| Publication Type: | Journal Article; Observational Study; Multicenter Study |
| Journal Info: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 0370500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-1891 (Electronic) Linking ISSN: 00029394 NLM ISO Abbreviation: Am J Ophthalmol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
